GTR 86708643
Bids Are Invited For Registration Of Prices For Purchasing Medicines - Oncology
ICB — International Competitive Bid
Closed
South America
Tender Information
GTR Reference
86708643
Tendering Authority
Subscribe to view
Tender No
19000-092/2024
Financer Name
Self-Funded
Work Title
Bids Are Invited For Registration Of Prices For Purchasing Medicines - Oncology
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
15-10-2024
Closed
Work Detail
Folinic Acid 10 Mg/Ml Injectable Solution (Ampule-Vial 30 Ml)., Afatinib 30 Mg Tablet In Blister., Afatinib 40 Mg Tablet., Anastrozole 1 Mg Tablet., Bicalutamide 50 Mg Tablet., 10/02/2024, Capecitabine 500 Mg Tablet, Cyproterone 50 Mg Tablet, Docetaxe 40 Mg/Ml Injectable Solution (2 Ml Vial-Ampule), Erlotinib 100 Mg Tablet, Erlotinib 25 Mg Tablet, Exemestane 25 Mg Tablet, Fluorouracil 50 Mg/Ml Injectable Solution (50 Ml Ampoule Vial), Fulvestrant 50 Mg/Ml Injectable Solution (5 Ml Syringe), Gefitinib 250 Mg Tablet, Irinotecan 20 Mg/Ml Injectable Solution (5 Ml Ampoule Vial), Leuprorelin 22, 5 Mg Lyophilic Powder For Injection Solution (Ampule Vial)., Megestrol 160 Mg Tablet., Mitoxantrone 2 Mg/Ml Injection Solution (10 Ml Ampoule Vial)., Paclitaxel 6Mg/Ml Injection Solution (50 Ml Ampoule Vial). , Pemetrexed 100 Mg Lyophilic Powder For Solution For Injection (Ampule)., Pemetrexed 500 Mg Lyophilic Powder For Solution For Injection (Vial.), Tamoxifen 20 Mg Tablet, Temozolomide 250 Mg Tablet, Topotecan 4 Mg Powder For Solution For Injection (Ampule Vial)., Triptorelin 3.75 Mg Lyophilic Powder For Injectable Suspension (Ampule Vial).
Key Value
Tender Value
5,119,228 - BRL
Tender Documents
Global Tender Document
193ac31f-4f01-470b-b89e-225ef6e1037d.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.